Folfiri-aflibercept vs folfiri-bevacizumab as second line treatment of RAS mutated metastatic colorectal cancer in real practice
Saved in:
Published in: | Annals of oncology Vol. 29 Suppl 8; p. viii160 |
---|---|
Main Authors: | , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
England
01-10-2018
|
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Author | Cassata, A Avallone, A Ottaiano, A Tafuto, S Nasti, G De Divitiis, C Capozzi, M De Stefano, A |
---|---|
Author_xml | – sequence: 1 givenname: A surname: Ottaiano fullname: Ottaiano, A organization: SSD Innovative Therapies for Abdominal Metastases - Abdominal Oncology, Istituto Nazionale Tumori, IRCCS, Fondazione "G. Pascale", Naples, Italy – sequence: 2 givenname: M surname: Capozzi fullname: Capozzi, M organization: Abdominal Oncology, Istituto Nazionale Tumori, IRCCS, Fondazione "G. Pascale", Naples, Italy – sequence: 3 givenname: C surname: De Divitiis fullname: De Divitiis, C organization: Abdominal Oncology, Istituto Nazionale Tumori, IRCCS, Fondazione "G. Pascale", Naples, Italy – sequence: 4 givenname: A surname: Cassata fullname: Cassata, A organization: Abdominal Oncology, Istituto Nazionale Tumori, IRCCS, Fondazione "G. Pascale", Naples, Italy – sequence: 5 givenname: A surname: De Stefano fullname: De Stefano, A organization: Abdominal Oncology, Istituto Nazionale Tumori, IRCCS, Fondazione "G. Pascale", Naples, Italy – sequence: 6 givenname: S surname: Tafuto fullname: Tafuto, S organization: Abdominal Oncology, Istituto Nazionale Tumori, IRCCS, Fondazione "G. Pascale", Naples, Italy – sequence: 7 givenname: A surname: Avallone fullname: Avallone, A organization: Abdominal Oncology, Istituto Nazionale Tumori, IRCCS, Fondazione "G. Pascale", Naples, Italy – sequence: 8 givenname: G surname: Nasti fullname: Nasti, G organization: SSD Innovative Therapies for Abdominal Metastases - Abdominal Oncology, Istituto Nazionale Tumori, IRCCS, Fondazione "G. Pascale", Naples, Italy |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32136276$$D View this record in MEDLINE/PubMed |
BookMark | eNo9kMtKxDAUhoOMOBd9ADeSF-iYNG2aLIfBUWFA8LIu6ckJRHoj6QyMKx_dSkdX_-HnfP_iW5JZ27VIyC1na860uDftWMB9Y0-p4muW5hdkwXOpE8UyPiMLplORFLnI5mQZ4ydjTOpUX5G5SLmQaSEX5HvX1c4HnxhX-woDYD_QY6TuXFd4NOC_Do2pqIk0InStpbVvkQ4BzdBgO9DO0dfNG20OgxnQ0gYHE8fTA4Wu7gLCYGoKpgUM1Ld05GraBwPjB16TS2fqiDfnXJGP3cP79inZvzw-bzf7BHih8sTlDDIFTEmFKkewTKoiBYW504ynWldW6KoymTHa5pmTGfKKYYHWFVJlQqwIn3YhdDEGdGUffGPCqeSs_LVZTjbLyWY52hyZu4npD1WD9p_40yd-AISmd7w |
ContentType | Journal Article |
DBID | NPM AAYXX CITATION |
DOI | 10.1093/annonc/mdy281.025 |
DatabaseName | PubMed CrossRef |
DatabaseTitle | PubMed CrossRef |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1569-8041 |
ExternalDocumentID | 10_1093_annonc_mdy281_025 32136276 |
Genre | Journal Article |
GroupedDBID | --- -E4 .2P .86 .I3 .XZ .ZR 08P 0R~ 0SF 0U7 1TH 23M 2WC 4.4 482 48X 53G 5GY 5VS 5WA 6.Y 6J9 70D AAEDW AAJKP AAJQQ AAKAS AAKUH AALRI AAMVS AAOGV AAPNW AAUQX AAXUO ABEUO ABIXL ABJNI ABKDP ABLJU ABNKS ABOCM ABQLI ABQTQ ABSAR ABSMQ ABVKL ABZBJ ACGFO ACGFS ACMRT ACPQN ACPRK ACUFI ACUTO ADBBV ADEYI ADHKW ADHZD ADJQC ADOCK ADRIX ADRTK ADVLN ADYVW ADZCM ADZXQ AEGPL AEGXH AEHUL AEJOX AEKPW AEKSI AEMDU AENEX AENZO AEPUE AEWNT AFETI AFIYH AFJKZ AFOFC AFSHK AFXEN AGINJ AGKEF AGKRT AGSYK AHMBA AHXPO AIAGR AIJHB AITUG AKRWK ALMA_UNASSIGNED_HOLDINGS ALUQC AMRAJ APIBT APWMN AQKUS ASPBG ATTQO AVWKF AXUDD AZFZN BAWUL BAYMD BGNMA BHONS BTRTY BVRKM BZKNY C1A CAG CDBKE CKLRP COF CS3 CZ4 DAKXR DIK DILTD DL5 D~K E3Z EBS EE~ EJD EX3 F9B FDB FEDTE GJXCC GX1 H13 H5~ HAR HVGLF HW0 HZ~ I09 IH2 IHE IOX J21 KAQDR KDC KOM KOP KQ8 KSI KSN LAK M-Z M41 M49 M4Y MBLQV MHKGH N9A NCXOZ NGC NOYVH NPM NTWIH NU- NU0 NVLIB O9- OAWHX ODMLO OJQWA OK1 OVD P2P P6G PAFKI PB- PEELM PQQKQ Q1. Q5Y QBD R44 RD5 RNI ROL ROX ROZ RPX RW1 RXO RZC RZE RZF RZO SDH TCURE TEORI TJX TMA TR2 U2A W8F WOQ WOW X7H YAYTL YFH YKOAZ ZKX ZXP ~91 AAYXX CITATION |
ID | FETCH-LOGICAL-c1785-f50c48c0868e85ecd06872c8e5f901299bd39bba4aa9d54f64e1b0e7edf768433 |
ISSN | 0923-7534 |
IngestDate | Thu Nov 21 20:48:42 EST 2024 Wed Oct 16 00:46:54 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c1785-f50c48c0868e85ecd06872c8e5f901299bd39bba4aa9d54f64e1b0e7edf768433 |
OpenAccessLink | https://academic.oup.com/annonc/article-pdf/29/suppl_8/mdy281.025/26139692/mdy281.025.pdf |
PMID | 32136276 |
ParticipantIDs | crossref_primary_10_1093_annonc_mdy281_025 pubmed_primary_32136276 |
PublicationCentury | 2000 |
PublicationDate | 2018-Oct 2018-10-00 |
PublicationDateYYYYMMDD | 2018-10-01 |
PublicationDate_xml | – month: 10 year: 2018 text: 2018-Oct |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Annals of oncology |
PublicationTitleAlternate | Ann Oncol |
PublicationYear | 2018 |
SSID | ssj0006929 |
Score | 2.31483 |
SourceID | crossref pubmed |
SourceType | Aggregation Database Index Database |
StartPage | viii160 |
Title | Folfiri-aflibercept vs folfiri-bevacizumab as second line treatment of RAS mutated metastatic colorectal cancer in real practice |
URI | https://www.ncbi.nlm.nih.gov/pubmed/32136276 |
Volume | 29 Suppl 8 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1La9wwEBabFEIupe8mfaBDTzUmfsmPY0g2pJS2h6TQm5H1AEHXXtZeQ_fUn54Zy491m0J76MUYWbaxvo_RjDzziZB3gnkhEyJxlQ4xQPEit-CBgpjH137hy4x3SF_fJJ-_pZfLaLlYDFIVU9t_RRraAGusnP0HtMeHQgOcA-ZwBNTh-Fe4X1XftdkYl-sucwSzVpwWRRdsc6FaLsxuu-IFbjFTYzwsnc7XnHLOUaDk_MZZbdETlbjLNMfCIyMc1LhGG4mqIsiXja2HwXKuvtxq39ud1JmrUszW7780DQdiVrPV1Au-rnY7M1ujvVRglVvTmF4LYepb17zh0_39yoWfjjlwMPH01jbOXBRA2jfHQeZ0G5o66Z5dbY0xvt144Debb_WweFnCp8DJSv4IUhRiZfu9AaT1qoM8DHyYtJNf9LftjN5fOiAPArBbXYT-4eM4scfgSg4_xrPwzL7xbHrfMTkanjDzcmbxSue33D4iD_uAg55bpjwmC1U-IUef-pSKp-TnPYShbU3vIQzlNbWEoUgYOhKGVpoCYWhPGDoRhk6EoZYw1JQUCUMHwjwjX6-WtxfXbr8thyv8JGWuZp6IUgGxcKpSpoT04jQJRKqYznBZMytkmBUFjzjPJIt0HCm_8FSipMa_vmH4nBzCyKmXhOo4VIypJIPgKYqConPBiyDR2pehkvKEvB-GMV9b9ZXcZk2EuR3-3A5_DvedkBd2oMeuAxqnf7zyihxPzHxNDpvNVr0hB7Xcvu2wvwNvEYNf |
link.rule.ids | 315,782,786,27933,27934 |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Folfiri-aflibercept+vs+folfiri-bevacizumab+as+second+line+treatment+of+RAS+mutated+metastatic+colorectal+cancer+in+real+practice&rft.jtitle=Annals+of+oncology&rft.au=Ottaiano%2C+A&rft.au=Capozzi%2C+M&rft.au=De+Divitiis%2C+C&rft.au=Cassata%2C+A&rft.date=2018-10-01&rft.eissn=1569-8041&rft.volume=29+Suppl+8&rft.spage=viii160&rft_id=info:doi/10.1093%2Fannonc%2Fmdy281.025&rft_id=info%3Apmid%2F32136276&rft.externalDocID=32136276 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0923-7534&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0923-7534&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0923-7534&client=summon |